These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9265010)

  • 1. [Blood pressure monitoring in left ventricular hypertrophy].
    Kraft K
    Internist (Berl); 1997 Jun; 38(6):616. PubMed ID: 9265010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension plus left ventricular hypertrophy. Prognosis can now be significantly improved].
    Einecke D
    MMW Fortschr Med; 2002 Apr; 144(14):4-5. PubMed ID: 12014276
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrophy and improved prognosis: some hope now . . . or hype?
    Lip GY
    Circulation; 2001 Oct; 104(14):1582-4. PubMed ID: 11581130
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension?
    Kizer JR; Devereux RB
    Am J Hypertens; 2006 May; 19(5):439-42. PubMed ID: 16647610
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of left ventricular hypertrophy in primary hypertension and therapeutic modification by antihypertensive drugs].
    Schiemann AL; Stimpel M
    Praxis (Bern 1994); 1997 Jul; 86(27-28):1101-6. PubMed ID: 9324718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LVH and hypertension: is treating the pressure not enough?
    Mandell BF
    Cleve Clin J Med; 2010 Jun; 77(6):344. PubMed ID: 20516242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Better prognosis in hypertension and left ventricular hypertrophy. LIFE Study sets new standard].
    MMW Fortschr Med; 2002 May; 144(20):60-1. PubMed ID: 12119887
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regression of left ventricular hypertrophy with antihypertensive therapy].
    Follath F
    Ther Umsch; 1998 Sep; 55(9):539-41. PubMed ID: 9789465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlling blood pressure by centrally acting drugs--still a topic?].
    Steckelings UM; Unger T
    Fortschr Med; 1994 Jan; 112(3):25-6. PubMed ID: 8144121
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of left ventricular hypertrophy with cardiovascular mortality.
    Sharpe N
    Int J Clin Pract Suppl; 2000 May; (110):16-22. PubMed ID: 10912303
    [No Abstract]   [Full Text] [Related]  

  • 19. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-drug therapy and reduction of left ventricular mass in hypertension.
    Gottdiener JS
    Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.